Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Korea Allows Sales Of OTC Products In Supermarkets July 21, But Distribution Remains A Challenge

This article was originally published in PharmAsia News

Executive Summary

SEOUL - South Koreans are expected to be able to purchase 48 new over-the-counter products at supermarkets and conveniences stores, previously only available at pharmacies, beginning July 21, but consumers found that companies need more time to allow for the expanded distribution and manufacturing

You may also be interested in...

Dong-A Wins Approvals From Otsuka, GSK For Split Into Holding Company

Dong-A Pharmaceutical is pushing to create a favorable environment for a temporary shareholder meeting on Jan. 28, though the third-largest shareholder, the National Pension Service, is opposed to a proposal to float a holding company.

Korea’s Dong-A Pharmaceutical Inks JV To Build Plant In Mongolia

Struggling from a recent indictment of over rebates, Korea’s leading pharma seeks new momentum in one of the most sparsely populated countries in the world.

South Korea’s Health Ministry Takes Narrow View On OTC Sales, Limiting Products Like J&J’s Tylenol

After nearly two years of debate, South Korea’s health ministry will allow 13 OTC products to be sold in 24-hour convenience shops, but excludes most supermarkets.

Related Content

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts